Vaccine Information Statements |
|
|
|
|
|
Up-to-date translations |
|
|
|
| You
are encouraged to distribute the current English version at the same time as the translation. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Out-of-date translations |
|
|
|
| The translations for
some VISs on our website are from previously published English-language
versions that have since been updated. Unfortunately, IAC is not always
able to obtain translations as updates are issued. Please ensure that your
patients receive information consistent with the current of
the following VISs. |
|
|
|
|
| KAREN TRANSLATION OF THE MAY 3, 2011 HPV (Gardasil) VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
Minor changes to wording. |
|
|
|
| • |
|
ACIP recommendations for males. |
|
|
|
|
| KAREN TRANSLATION OF THE MARCH 13, 2008 MMR VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
Section 2, sentence has been
added noting that children younger than 12 months who are
traveling overseas should get a dose of MMR; |
|
|
|
| • |
|
Section 3, a note has been added asking the patient to tell their provider if they received another vaccine within the
past 4 weeks (to alert the provider of the possibility of administering two live vaccines too close together); |
|
|
|
| • |
|
Section 4, the statement that minor problems usually occur 7-12 days after the shot was changed to the more accurate 6-14
days; and |
|
|
|
| • |
|
Box noting the risk of adverse events following MMRV
was removed, as it is not relevant for patients receiving
MMR. |
|
|
|
| • |
|
This VIS is the
first to feature a 2D barcode, which will allow providers to
scan selected information into the patient's record or into
an immunization information system. |
|
|
|
| KAREN TRANSLATION OF THE JANUARY 30, 2008 MULTI-VACCINE VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC update: |
|
| • |
|
Multi-vaccine VIS update. An updated interim edition of the pediatric multi-vaccine VIS, dated September 18, 2008, has been posted. It has been made consistent with the recently updated rotavirus VIS by noting the availability of two rotavirus vaccines in the "Routine Childhood Vaccines" section and adding "irritability" to the mild problems listed for rotavirus in the "Vaccine Risks" section. Otherwise, the VIS is identical to the 1/30/08 edition. Providers using the multi-vaccine VIS when administering Rotarix should begin using the new edition now. When Rotarix is not administered, the older edition may be used until stocks are used up. (9/18/08) |
|
|
|
| KAREN TRANSLATION OF THE SEPTEMBER 30, 2002 PCV7 VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC update: |
|
| • |
|
The CDC posted an updated interim PCV VIS on 12/9/08. The main reason is to incorporate recent changes in recommendations for 2-4 year olds, but there are other changes throughout as well. There are no changes in contraindications or adverse events, but to prevent parents from getting confused about the differences in indications (especially when the vaccine is administered to 2-4 year olds) it would be best for providers to start using the new version right away. Existing stocks CAN still be used temporarily if immediately switching to the new version is a problem. |
|
|
| Thanks to the Minnesota Department of Health for their translations. |
A-Z
